Biomedical Informatician Atul Butte Dies at 55

Atul Butte mined big data to fuel biomedical insights to advance precision medicine.

Written byLaura Tran, PhD
| 2 min read
Image of Atul Butte.
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Atul Butte, a biomedical informatician and pediatrician, passed away at age 55 following a long battle with cancer, according to colleagues on social media. Known for his contributions to bridging data science and clinical practice, his work focused on diving into a sea of data in search of ways to improve health and precision medicine.

Butte was born in Philadelphia, Pennsylvania in 1970. He earned his undergraduate and medical degrees from Brown University. Later, he matriculated at Massachusetts Institute of Technology where he received a master’s degree in medical informatics and a PhD in medical engineering and medical physics.

In 2005, Butte moved to California and served as faculty at Stanford University for more than a decade. There, he pioneered methods to mine publicly available genomic and biomedical data to uncover novel therapies and reclassify diseases.1 In 2015, Butte began a new role as the director of the Institute for Computational Health Sciences at the University of California, San Francisco. He also served as the chief data scientist for the entire University of California Health System until his passing.

In addition to his pursuits in academia, Butte was an entrepreneur. He co-founded three biotechnology companies related to genome sequencing, the development of diagnostics for pregnancy complications, and bioprospecting new uses for existing drugs within open-access data.

Butte received many accolades throughout his career. The Obama Administration recognized him as a White House Champion of Change in Open Science in 2013 for promoting science through publicly available data. In addition, he was elected to the National Academy of Medicine (2015), the International Society for Computational Biology (2021), and the American Association for the Advancement of Science (2022).

Outside of his scientific work, Butte left a lasting impression within his community. One colleague, data scientist Avisek Deyati, remarked in an online comment, “His work transformed how we harness big data to advance precision medicine, and his mentorship inspired an entire generation of scientists. His legacy will continue to shape our field for years to come.” Others described Butte as an individual full of energy, smiles, compassion, and ideas. Butte is survived by his wife and daughter.

  1. Dudley JT, et al. Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinform. 2011;12(4):303-311.
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

  • Laura Tran, PhD

    Laura Tran is an Assistant Editor at The Scientist. She has a background in microbiology. Laura earned her PhD in integrated biomedical sciences from Rush University, studying how circadian rhythms and alcohol impact the gut. While completing her studies, she wrote for the Chicago Council on Science and Technology and participated in ComSciCon Chicago in 2022. In 2023, Laura became a science communication fellow with OMSI, continuing her passion for accessible science storytelling.

    View Full Profile
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies